Rise in the incidences of thyroid disorders and obesity are the factors responsible for the growth of levothyroxine market. Levothyroxine regulates the secretion of thyroid, thereby preventing hypothyroidism.
Various awareness campaigns are being conducted by the government and non-government bodies to apprise the individuals of the vitality concerned with use of levothyroxine.
The companies operating in the levothyroxine market are exploring the usage of mass spectrometry in order to enhance quality of and safety associated with consumption of levothyroxine.
They are also trying to introduce combination therapy, with the latest being using levothyroxine with liothyronine in order to improve biometric outcomes.
Levothyroxine is referred to as a medicine used for treating hypothyroidism, an underactive thyroid gland. Levothyroxine is available only on prescription and compensates for the missing thyroid hormone.
Levothyroxine is also called L-thyroxine or Synthroid. As several cardiac functions that include cardiac output, heart rate, and systemic vascular resistance are closely associated with the level of thyroid, over-treating with levothyroxine is likely to cause an increase in heartbeats, cardiac contractility, and cardiac wall thickness, and may also end up precipitating arrhythmias or angina, especially in those suffering from cardiovascular diseases and the elderly population.
Over-replacement of levothyroxine may also cause decreased bone mineral density, especially in the post-menopausal women. It is therefore advisable to consume levothyroxine only on the advice of medical practitioner.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Levothyroxine is one of the synthetic versions of a hormone called thyroxine. It performs the function of replacing thyroxine if the thyroid gland can’t produce it, thereby averting symptoms of hypothyroidism.
Levothyroxine, when taken in proper doses, helps in returning the thyroid hormone to optimum levels. Levothyroxine (LT4) doses suppress serum thyrotropin (TSH) levels and are used for preventing propagation of thyroid cancer as well as thyroid nodules.
Oral levothyroxine is basically recommended to treat primary, secondary, and tertiary modes of hypothyroidism.
As per Siemens Healthineers, around 200 million people worldwide suffer from some or the other type of thyroid disease. It further states that 50% of the rest of the population are unmindful of the symptoms of thyroid disorders.
Rise in the number of patients suffering from thyroid disorders and need to combat these disorders are thus accelerating the levothyroxine market growth.
Obesity is one amongst the prominent risk factors triggering hyperthyroidism and hypothyroidism. As per the World Obesity Federation’s World Obesity Atlas 2023, the economic impact of being obese is likely to reach US$ 4.32 Tn every year by the year 2035 if preventive as well as curative measures are not taken.
It further states that this constitutes close to 3% of GDP and the trend, if continued unchecked, may end up making 51% of the global population obese by 2035.
An exponential increase in obese population worldwide is thus driving the demand for levothyroxine sodium tablets and this trend is expected to continue during the forecast period.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest levothyroxine market statistics, North America dominated the levothyroxine sodium landscape in 2023 and the scenario is expected to remain unchanged during the forecast period. This is attributed to growing awareness amongst the population of the U.S. regarding thyroid disorders.
As per the American Thyroid Association, around 12% of the U.S. population is expected to suffer from thyroid disorders at some stage in their lives. It further states that as of now 20 million Americans have been adversely affected.
Europe’s noteworthy levothyroxine market share is ascribed to higher prevalence of thyroid disorders amongst the elderly population. Asia Pacific follows suit with China leading from the front.
The key players in the levothyroxine market are working toward upgradation of their existing product portfolio to strengthen their position. For instance, AbbVie is progressing with regards to its pipeline programs in which it is targeting conditions such as Parkinson’s disease, Crohn’s disease, wet AMD, viral diseases, autoimmune diseases, aesthetics, and neurological diseases.
AbbVie Inc., Mylan N.V., Merck & Co., Inc., Pfizer Inc., Lannett Company Inc, Novartis AG, Fresenius Kabi, Piramal Critical Care, and Abbott Laboratories are some of the key players covered in the levothyroxine market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 3.8 Bn |
| Market Forecast (Value) in 2034 | US$ 5.4 Bn |
| Growth Rate (CAGR) | 3.3% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 3.8 Bn in 2023
It is projected to grow at a CAGR of 3.3% from 2024 to 2034
Growing prevalence of thyroid disorders and rise in incidence of obesity
Hospital pharmacies segment accounted for the largest share in 2023
North America was the dominant region in 2023
AbbVie Inc., Mylan N.V., Merck & Co., Inc., Pfizer Inc., Lannett Company Inc, Novartis AG, Fresenius Kabi, Piramal Critical Care, and Abbott Laboratories
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Levothyroxine Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Levothyroxine Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Levothyroxine Market Analysis and Forecast, by Route of Administration
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Route of Administration, 2020-2034
6.3.1. Oral
6.3.2. Injectables
6.4. Market Attractiveness Analysis, by Route of Administration
7. Global Levothyroxine Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Distribution Channel, 2020-2034
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Pharmacies
7.4. Market Attractiveness Analysis, by Distribution Channel
8. Global Levothyroxine Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2020-2034
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Levothyroxine Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Route of Administration, 2020-2034
9.3.1. Oral
9.3.2. Injectables
9.4. Market Value Forecast, by Distribution Channel, 2020-2034
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Market Value Forecast, by Country, 2020-2034
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Route of Administration
9.6.2. By Distribution Channel
9.6.3. By Country
10. Europe Levothyroxine Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Route of Administration, 2020-2034
10.3.1. Oral
10.3.2. Injectables
10.4. Market Value Forecast, by Distribution Channel, 2020-2034
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Market Value Forecast, by Country/Sub-region, 2020-2034
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Route of Administration
10.6.2. By Distribution Channel
10.6.3. By Country/Sub-region
11. Asia Pacific Levothyroxine Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Route of Administration, 2020-2034
11.3.1. Oral
11.3.2. Injectables
11.4. Market Value Forecast, by Distribution Channel, 2020-2034
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Route of Administration
11.6.2. By Distribution Channel
11.6.3. By Country/Sub-region
12. Latin America Levothyroxine Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Route of Administration, 2020-2034
12.3.1. Oral
12.3.2. Injectables
12.4. Market Value Forecast, by Distribution Channel, 2020-2034
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Route of Administration
12.6.2. By Distribution Channel
12.6.3. By Country/Sub-region
13. Middle East & Africa Levothyroxine Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Route of Administration, 2020-2034
13.3.1. Oral
13.3.2. Injectables
13.4. Market Value Forecast, by Distribution Channel, 2020-2034
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Route of Administration
13.6.2. By Distribution Channel
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2023)
14.3. Company Profiles
14.3.1. AbbVie Inc.
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. Mylan N.V.
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. Merck & Co., Inc.
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. Pfizer Inc.
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Lannett Company Inc
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Novartis AG
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. Fresenius Kabi
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. Piramal Critical Care
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
14.3.9. Abbott Laboratories
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Financial Overview
14.3.9.5. Strategic Overview
List of Tables
Table 01: Global Levothyroxine Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
Table 02: Global Levothyroxine Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
Table 03: Global Levothyroxine Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 04: North America Levothyroxine Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 05: North America Levothyroxine Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
Table 06: North America Levothyroxine Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
Table 07: Europe Levothyroxine Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 08: Europe Levothyroxine Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
Table 09: Europe Levothyroxine Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
Table 10: Asia Pacific Levothyroxine Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 11: Asia Pacific Levothyroxine Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
Table 12: Asia Pacific Levothyroxine Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
Table 13: Latin America Levothyroxine Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Latin America Levothyroxine Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
Table 15: Latin America Levothyroxine Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
Table 16: Middle East & Africa Levothyroxine Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 17: Middle East & Africa Levothyroxine Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
Table 18: Middle East & Africa Levothyroxine Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
List of Figures
Figure 01: Global Levothyroxine Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Levothyroxine Market Revenue (US$ Bn), by Route of Administration, 2023
Figure 03: Global Levothyroxine Market Value Share, by Route of Administration, 2023
Figure 04: Global Levothyroxine Market Revenue (US$ Bn), by Distribution Channel, 2023
Figure 05: Global Levothyroxine Market Value Share, by Distribution Channel, 2023
Figure 06: Global Levothyroxine Market Value Share, by Region, 2023
Figure 07: Global Levothyroxine Market Value (US$ Bn) Forecast, 2020-2034
Figure 08: Global Levothyroxine Market Value Share Analysis, by Route of Administration, 2023 and 2034
Figure 09: Global Levothyroxine Market Attractiveness Analysis, by Route of Administration, 2020-2034
Figure 10: Global Levothyroxine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 11: Global Levothyroxine Market Attractiveness Analysis, by Distribution Channel, 2020-2034
Figure 12: Global Levothyroxine Market Value Share Analysis, by Region, 2023 and 2034
Figure 13: Global Levothyroxine Market Attractiveness Analysis, by Region, 2020-2034
Figure 14: North America Levothyroxine Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 15: North America Levothyroxine Market Attractiveness Analysis, by Country, 2020-2034
Figure 16: North America Levothyroxine Market Value Share Analysis, by Country, 2023 and 2034
Figure 17: North America Levothyroxine Market Value Share Analysis, by Route of Administration, 2023 and 2034
Figure 18: North America Levothyroxine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 19: North America Levothyroxine Market Attractiveness Analysis, by Route of Administration, 2020-2034
Figure 20: North America Levothyroxine Market Attractiveness Analysis, by Distribution Channel, 2020-2034
Figure 21: Europe Levothyroxine Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 22: Europe Levothyroxine Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
Figure 23: Europe Levothyroxine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 24: Europe Levothyroxine Market Value Share Analysis, by Route of Administration, 2023 and 2034
Figure 25: Europe Levothyroxine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 26: Europe Levothyroxine Market Attractiveness Analysis, by Route of Administration, 2020-2034
Figure 27: Europe Levothyroxine Market Attractiveness Analysis, by Distribution Channel, 2020-2034
Figure 28: Asia Pacific Levothyroxine Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 29: Asia Pacific Levothyroxine Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
Figure 30: Asia Pacific Levothyroxine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 31: Asia Pacific Levothyroxine Market Value Share Analysis, by Route of Administration, 2023 and 2034
Figure 32: Asia Pacific Levothyroxine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 33: Asia Pacific Levothyroxine Market Attractiveness Analysis, by Route of Administration, 2020-2034
Figure 34: Asia Pacific Levothyroxine Market Attractiveness Analysis, by Distribution Channel, 2020-2034
Figure 35: Latin America Levothyroxine Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 36: Latin America Levothyroxine Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
Figure 37: Latin America Levothyroxine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 38: Latin America Levothyroxine Market Value Share Analysis, by Route of Administration, 2023 and 2034
Figure 39: Latin America Levothyroxine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 40: Latin America Levothyroxine Market Attractiveness Analysis, by Route of Administration, 2020-2034
Figure 41: Latin America Levothyroxine Market Attractiveness Analysis, by Distribution Channel, 2020-2034
Figure 42: Middle East & Africa Levothyroxine Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 43: Middle East & Africa Levothyroxine Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
Figure 44: Middle East & Africa Levothyroxine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 45: Middle East & Africa Levothyroxine Market Value Share Analysis, by Route of Administration, 2023 and 2034
Figure 46: Middle East & Africa Levothyroxine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 47: Middle East & Africa Levothyroxine Market Attractiveness Analysis, by Route of Administration, 2020-2034
Figure 48: Middle East & Africa Levothyroxine Market Attractiveness Analysis, by Distribution Channel, 2020-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Levothyroxine Market
